4/10
06:25 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
4/10
06:24 pm
vor
Form 4 Vor Biopharma Inc. For: Apr 08 Filed by: Kolchinsky Peter
Medium
Report
Form 4 Vor Biopharma Inc. For: Apr 08 Filed by: Kolchinsky Peter
4/9
08:02 pm
vor
Form 3 Vor Biopharma Inc. For: Apr 01 Filed by: Sokolove Jeremy Brett
Low
Report
Form 3 Vor Biopharma Inc. For: Apr 01 Filed by: Sokolove Jeremy Brett
4/8
06:45 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
4/6
06:51 pm
vor
Form 4 Vor Biopharma Inc. For: Apr 02 Filed by: Kolchinsky Peter
Medium
Report
Form 4 Vor Biopharma Inc. For: Apr 02 Filed by: Kolchinsky Peter
4/1
05:29 pm
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: TCG Crossover GP II, LLC
Medium
Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: TCG Crossover GP II, LLC
4/1
05:16 pm
vor
Form 3 Vor Biopharma Inc. For: Mar 30 Filed by: TCG Crossover GP III, LLC
Medium
Report
Form 3 Vor Biopharma Inc. For: Mar 30 Filed by: TCG Crossover GP III, LLC
4/1
05:10 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
3/30
08:07 am
vor
Form S-8 Vor Biopharma Inc.
Low
Report
Form S-8 Vor Biopharma Inc.
3/30
08:03 am
vor
Form 10-K Vor Biopharma Inc. For: Dec 31
Low
Report
Form 10-K Vor Biopharma Inc. For: Dec 31
3/27
08:03 am
vor
Form 8-K Vor Biopharma Inc. For: Mar 26
Low
Report
Form 8-K Vor Biopharma Inc. For: Mar 26
3/16
04:15 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
2/17
07:00 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Verve Capital Ltd
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Verve Capital Ltd
2/17
06:22 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.
2/17
04:14 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: GREAT POINT PARTNERS LLC
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: GREAT POINT PARTNERS LLC
2/17
04:03 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
2/13
07:47 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Qiming Venture Partners VIII-HC, L.P.
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Qiming Venture Partners VIII-HC, L.P.
2/5
04:07 pm
vor
Form 424B3 Vor Biopharma Inc.
High
Report
Form 424B3 Vor Biopharma Inc.
2/5
01:41 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: FMR LLC
2/5
06:05 am
vor
Form EFFECT Vor Biopharma Inc.
Low
Report
Form EFFECT Vor Biopharma Inc.
1/29
04:15 pm
vor
Form S-3 Vor Biopharma Inc.
Medium
Report
Form S-3 Vor Biopharma Inc.